Related Experiment Video
Updated: Oct 31, 2025

Advances in Human Induced Pluripotent Stem Cell-Derived Chimeric Antigen Receptor-Expressing Natural Killer Cells
Published on: February 14, 2025
Immunotherapy for cholangiocarcinoma: a 2021 update
Nikolaos Charalampakis1, Georgios Papageorgiou1, Sergios Tsakatikas1
1Department of Medical Oncology, Metaxa Cancer Hospital of Piraeus, Piraeus, 185 37, Greece.
Immunotherapy offers hope for cholangiocarcinoma (CCA), a rare cancer with poor outcomes. Research into novel treatments like cancer vaccines and immune checkpoint inhibitors is underway to improve patient prognosis.
Area of Science:
- Oncology
- Immunology
Background:
- Cholangiocarcinoma (CCA) is a rare cancer with a poor prognosis.
- Current treatments offer limited efficacy for CCA.
- Immunotherapy has transformed cancer care but has not yet significantly advanced CCA management.
Purpose of the Study:
- To review the rationale and clinical data for using immunotherapy in CCA.
- To present ongoing clinical trials and their key findings in CCA immunotherapy.
Main Methods:
- Review of existing literature on immunotherapy for CCA.
- Analysis of data from ongoing clinical trials.
Main Results:
- Novel immunotherapeutic strategies are under investigation for CCA.
- These include cancer vaccines, oncolytic viruses, adoptive cell therapy, and combination therapies.
- Biomarker research is crucial for predicting treatment response.
Conclusions:
- Immunotherapy holds promise for improving outcomes in cholangiocarcinoma.
- Further research and clinical trials are essential to realize its potential.
- Identifying predictive biomarkers is key for personalized immunotherapy in CCA.
More Related Videos
06:38An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis
Published on: September 12, 2019
09:11Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma
Published on: May 24, 2024
Related Concept Videos
Tumor Immunotherapy
Targeted Cancer Therapies
There are several types of targeted therapies against...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...